74783-2

Malignant cells [Presence] in Body fluid by Light microscopy

Active

Part Descriptions

LP31549-6   Malignant cells
In medicine, malignant is a clinical term that is used to describe a clinical course that progresses rapidly to death. It is typically applied to neoplasms that show aggressive behavior characterised by local invasion or distant metastasis. The change of cells from benign to malignant behavior is called malignant transformation. Usually this diagnosis is made by pathologic examination of tissues. However, often the physician during the history and physical examination can find that there have been changes in size or patient sensation and upon direct examination that there has been a change in the lesion itself. Malignant transformation is a synonym for progression to malignancy. Transformation may take place as a primary or a secondary process. Although malignant transformation may occur because of changes within the cell, it can be induced by inorganic toxic substances such as cadmium or arsenite and organics such as tobacco-specific nitrosamines. Copyright Text is available under the Creative Commons Attribution/Share-Alike License. See http://creativecommons.org/licenses/by-sa/3.0/ for details. Source: Wikipedia, Malignant cells (Wikipedia)

LP31549-6   Malignant cells
A neoplasm which invades serous cavities can cause malignant cells to be seen in body fluid specimens. The cells have increased cell and nuclear size, irregularly shaped nuclei, large nucleoli, high nuclear to cytomplasmic ratio, and atypical nuclear chromatin patterns. The cells can be numerous or rarely seen; some can form large clusters. Source: 2010 Hematology and Clinical Microscopy Glossary by College of Americal Pathologists (CAP). Source: Regenstrief Institute

LP7238-1   Body fld
The LOINC "Body fld" System represents body fluids other than serum, plasma, blood, urine, and cerebrospinal fluid. When a LOINC term with the System "Body fld" is used, the specific specimen source or body fluid type should be reported elsewhere with the result. Where more specific terms for pleural, peritoneal, synovial fluid, etc. exist, we encourage you to use the more specific terms. In contrast to "Body fld", the System "Asp" in LOINC represents the fluid withdrawn during an aspiration procedure from an abnormal collection of fluid, such as from an abscess or cyst. "Asp" is used for abnormal fluid collections that are aspirated, while "Body fld" is used for named body fluids, such as synovial fluid or peritoneal fluid, that are not inherently pathologic. Source: Regenstrief LOINC

Fully-Specified Name

Component

Malignant cells

Property

PrThr

Time

Pt

System

Body fld

Scale

Ord

Method

Microscopy.light

Additional Names

Short Name

Malignant cells Fld Ql Micro

Display Name

Malignant cells LM Ql (Body fld)

Consumer Name Alpha Get Info

Malignant cells, Body fluid

Example Answer List: LL1162-8

Basic Attributes

Class

HEM/BC

Type

Laboratory

First Released

Version 2.48

Last Updated

Version 2.56

Change Reason

The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016.

Order vs. Observation

Observation

Language Variants Get Info

Related Names

• B/F
• BF
• bod
• Bodies
• Body fluid
• Body fluid, unsp
• Cell
• Cellularity
• Fl
• Fld
• FLU
• Fluid
• HEMATOLOGY/CELL COUNTS
• LM
• Malig
• Micro
• Micros
• Microscopic
• Ordinal
• Point in time
• PR
• QL
• Qual
• Qualitative
• Random
• Screen

LOINC Terminology Service (API) using HL7^® FHIR^® Get Info

Requests to this service require a free LOINC username and password. Below is a sample of the possible capabilities. See the LOINC Terminology Service documentation for more information.

CodeSystem lookup

https://fhir.loinc.org/CodeSystem/$lookup?system=http://loinc.org&code=74783-2

Third Party Copyright

This material includes SNOMED Clinical Terms® (SNOMED CT®) which is used by permission of the International Health Terminology Standards Development Organisation (IHTSDO) under license. All rights reserved. SNOMED CT® was originally created by The College of American Pathologists. "SNOMED" and "SNOMED CT" are registered trademarks of the IHTSDO.

This material includes content from the US Edition to SNOMED CT, which is developed and maintained by the U.S. National Library of Medicine and is available to authorized UMLS Metathesaurus Licensees from the UTS Downloads site at https://uts.nlm.nih.gov.

Use of SNOMED CT content is subject to the terms and conditions set forth in the SNOMED CT Affiliate License Agreement. It is the responsibility of those implementing this product to ensure they are appropriately licensed and for more information on the license, including how to register as an Affiliate Licensee, please refer to http://www.snomed.org/snomed-ct/get-snomed-ct or info@snomed.org<mailto:info@snomed.org>. This may incur a fee in SNOMED International non-Member countries.

LOINC Copyright

Copyright © 2024 Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright © 1995-2024, Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee. See https://loinc.org/license for the full LOINC copyright and license.